Elucidating the mechanism of UL138 mediated suppression of lytic phase genes during human cytomegalovirus latency.
Elucidating the mechanism of UL138 mediated suppression of lytic phase genes during human cytomegalovirus latency.
批准号:
9753697
负责人:
Christopher Gelbmann
金额:
$4.95万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2020-08-31
关键词:
ABCC1 geneAIDS/HIV problemAdultArchitectureCell NucleusCell surfaceClinicalCytomegalovirusDiseaseEarly PromotersEpidermal Growth Factor ReceptorFibroblastsGenesGoalsGolgi ApparatusHistone Deacetylase InhibitorHumanImmuneImmune systemImmunocompromised HostInfectionLeadLifeLysineLysosomesLytic PhaseMaintenanceMediatingModelingMolecularPathway interactionsPatientsPlayPopulationProteinsRepressionResearchRoleSerial PassageSignal TransductionSorting - Cell MovementTestingTransmembrane DomainTransplantationTumor Necrosis Factor ReceptorValproic AcidViral ProteinsViruscellular targetingcombathistone demethylasehistone modificationhuman pathogenlatent infectionpathogenpreventrecruitsuccesstrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary
Human cytomegalovirus (HCMV) is a major human pathogen infecting 60-90% of the population. Its ability to
establish latency and persist for the life of the host contributes to its widespread success as a pathogen. While
infection in healthy adults is relatively asymptomatic HCMV can cause severe disease in immunocompromised
patients such as transplant and HIV/AIDS patients and those with undeveloped immune systems. Importantly
disease can be caused by virus reactivating after decades of latency when immune defenses are
compromised. The viral protein UL138 is required to establish and maintain latency and is retained in all
clinical isolates but lost upon serial passage in fibroblasts (25, 26, 28). UL138’s critical role during latency
makes it an ideal target to combat latent infection. When expressed from a latency defective HCMV strain
AD169, UL138 prevents histone deacetylase (HDAC) inhibitor valproic acid (VPA) induced expression of the
viral protein IE1 from the major immediate early promoter (MIEP); blocking the first step of a lytic infection (27).
This critical checkpoint determines whether HCMV will undergo a lytic or latent infection. Initial studies have
found UL138 prevents lysine demethylases (KDMs) from removing repressive histone modifications on the
MIEP (27). Intriguingly, UL138 localizes to the Golgi apparatus and has not been found in the nucleus where
its effect on the MIEP takes place.
The primary goal of this study is to identify how UL138 prevents demethylases from being recruited to
the MIEP allowing for the establishment of latency. A clearer understanding of how UL138 helps HCMV
establish and maintain latency is needed to develop treatments to combat latent HCMV and to clear the latent
reservoir. Through our studies possible cellular targets to modulate HCMV latency will be discovered. This
research is driven by the hypothesis that UL138 alters cellular trafficking of an unidentified protein(s)
preventing them from recruiting KDMs to the MIEP. Supporting this hypothesis UL138 contains four Golgi
sorting motifs and alters the subcellular localization of several proteins (33, 34, 35, 37). The requirement for
these sorting motifs and cellular sorting machinery for UL138 mediated suppression of the MIEP will be tested
and the proteins UL138 must interact with to silence the MIEP will be identified.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文